6 results
10-12G/A
NSTM
NovelStem International Corp.
28 Jun 23
Registration of securities (amended)
2:46pm
, regenerative medicine and disease therapy. NewStem established a discovery bio-platform based on haploid human embryonic stem cell technology for genome
10-12G/A
NSTM
NovelStem International Corp.
6 Dec 22
Registration of securities (amended)
5:52pm
the face of medical research as they play a pivotal role in cancer research, regenerative medicine and disease therapy. NewStem established a discovery
10-12G/A
NSTM
NovelStem International Corp.
13 Oct 22
Registration of securities (amended)
11:17am
role in cancer research, regenerative medicine and disease therapy. NewStem established a discovery bio-platform based on haploid human embryonic stem
10-12G
ovmms1as
2 Aug 22
Registration of securities
12:31pm
- Prev
- 1
- Next